Dimerix Limited ( (AU:DXB) ) just unveiled an announcement.
Dimerix Limited has announced the quotation of 1,000 new fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code DXB, effective from March 6, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing development projects, potentially impacting its market position and offering new opportunities for stakeholders.
More about Dimerix Limited
Dimerix Limited operates in the biotechnology industry, focusing on the development of pharmaceutical products. The company is involved in creating therapies for various medical conditions, aiming to address unmet medical needs in the healthcare market.
YTD Price Performance: 29.41%
Average Trading Volume: 2,458,186
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: A$245.9M
See more data about DXB stock on TipRanks’ Stock Analysis page.